US Stock MarketDetailed Quotes
ELAN Elanco Animal Health
- 13.260
- +0.220+1.69%
Close Apr 26 16:00 ET
6.55BMarket Cap-5304P/E (TTM)
13.360High12.920Low3.25MVolume13.030Open13.040Pre Close43.20MTurnover0.66%Turnover RatioLossP/E (Static)494.10MShares16.88052wk High1.05P/B6.52BFloat Cap7.88052wk Low--Dividend TTM491.64MShs Float37.610Historical High--Div YieldTTM3.37%Amplitude7.880Historical Low13.274Avg Price1Lot Size
Elanco Animal Health Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -40.04%271M | 1,107.69%157M | 4.76%198M | -80.45%61M | -133.87%-145M | -6.42%452M | -94.17%13M | 112.36%189M | 109.40%312M | -381.82%-62M |
| Net income from continuing operations | -1,478.21%-1.23B | -161.11%-141M | -1,586.15%-1.1B | -870.00%-97M | 101.96%103M | 83.85%-78M | 50.00%-54M | 37.50%-65M | 95.24%-10M | 183.61%51M |
| Operating gains losses | ---- | ---- | ---- | ---- | 0.00%1M | --20M | ---- | ---- | ---- | --1M |
| Depreciation and amortization | 1.76%694M | 1.79%171M | 3.59%173M | 3.51%177M | -1.70%173M | -4.75%682M | -3.45%168M | -1.76%167M | 0.59%171M | -12.87%176M |
| Deferred tax | -40.35%-80M | ---- | ---- | ---- | 128.57%2M | 61.49%-57M | ---- | ---- | ---- | 78.13%-7M |
| Other non cash items | -67.15%68M | 1,050.00%19M | -50.67%37M | -92.56%9M | -76.92%3M | 176.00%207M | -150.00%-2M | 837.50%75M | 1,444.44%121M | -81.94%13M |
| Change In working capital | 35.06%-300M | 289.61%146M | 2,800.00%27M | 34.62%-34M | -32.23%-439M | -425.00%-462M | -149.68%-77M | 98.11%-1M | -642.86%-52M | -81.42%-332M |
| -Change in receivables | -385.71%-40M | ---- | ---- | ---- | ---- | 140.00%14M | ---- | ---- | ---- | ---- |
| -Change in inventory | 40.52%-160M | ---- | ---- | ---- | ---- | -1,027.59%-269M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 4.08%-94M | ---- | ---- | ---- | ---- | 15.52%-98M | ---- | ---- | ---- | ---- |
| -Change in other current assets | 94.50%-6M | ---- | ---- | ---- | ---- | -536.00%-109M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -40.04%271M | 1,107.69%157M | 4.76%198M | -80.45%61M | -133.87%-145M | -6.42%452M | -94.17%13M | 112.36%189M | 109.40%312M | -381.82%-62M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 5.59%-169M | 53.95%-35M | 2.70%-36M | -16.22%-43M | -89.66%-55M | 66.23%-179M | -2.70%-76M | 91.61%-37M | -48.00%-37M | -390.00%-29M |
| Net PPE purchase and sale | 18.13%-140M | 46.75%-41M | 8.33%-33M | -17.95%-46M | -5.26%-20M | -7.55%-171M | 22.22%-77M | -44.00%-36M | -129.41%-39M | -5.56%-19M |
| Net intangibles purchase and sale | -7.69%-14M | --0 | --0 | -33.33%4M | -157.14%-18M | 65.79%-13M | -125.00%-2M | ---10M | 175.00%6M | 81.58%-7M |
| Net business purchase and sale | ---19M | --0 | ---3M | --0 | ---16M | --0 | --0 | --0 | --0 | --0 |
| Net other investing changes | -20.00%4M | 100.00%6M | --0 | 75.00%-1M | 66.67%-1M | -44.44%5M | -82.35%3M | 1,000.00%9M | ---4M | 57.14%-3M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 5.59%-169M | 53.95%-35M | 2.70%-36M | -16.22%-43M | -89.66%-55M | 66.23%-179M | -2.70%-76M | 91.61%-37M | -48.00%-37M | -390.00%-29M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 84.88%-83M | -65.48%-139M | 7.65%-157M | 141.05%39M | 187.00%174M | -361.43%-549M | -290.91%-84M | -173.59%-170M | -41.79%-95M | -10,100.00%-200M |
| Net issuance payments of debt | 84.66%-77M | -98.57%-139M | -1.30%-156M | 141.57%37M | 195.77%181M | -383.62%-502M | -288.89%-70M | -166.38%-154M | -32.84%-89M | -730.00%-189M |
| Net other financing activities | 87.23%-6M | --0 | 93.33%-1M | 128.57%2M | 36.36%-7M | -242.42%-47M | -122.58%-14M | -1,400.00%-15M | ---7M | 60.71%-11M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 84.88%-83M | -65.48%-139M | 7.10%-157M | 140.63%39M | 187.00%174M | -361.43%-549M | -290.91%-84M | -173.16%-169M | -43.28%-96M | -10,100.00%-200M |
| Net cash flow | ||||||||||
| Beginning cash position | -45.92%345M | -19.78%369M | -27.61%367M | -7.02%318M | -45.92%345M | 26.09%638M | 1.55%460M | -12.59%507M | -33.59%342M | 26.09%638M |
| Current changes in cash | 106.88%19M | 88.44%-17M | 129.41%5M | -68.16%57M | 91.07%-26M | -269.33%-276M | -176.17%-147M | 85.95%-17M | 214.04%179M | -955.88%-291M |
| Effect of exchange rate changes | 29.41%-12M | --0 | 90.00%-3M | 42.86%-8M | 80.00%-1M | 45.16%-17M | 500.00%32M | -400.00%-30M | -275.00%-14M | 80.00%-5M |
| End cash Position | 2.03%352M | 2.03%352M | -19.78%369M | -27.61%367M | -7.02%318M | -45.92%345M | -45.92%345M | 1.55%460M | -12.59%507M | -33.59%342M |
| Free cash flow | -56.34%117M | 275.76%116M | 15.38%165M | -93.19%19M | -107.95%-183M | -6.29%268M | -150.00%-66M | 123.44%143M | 125.00%279M | -158.82%-88M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg